SCHEMBL4827745

SCHEMBL4827745

CC1(C)C2C1C1C2C1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19133201 0.66
SCHEMBL18828483 0.62
SCHEMBL11827893 0.56
SCHEMBL6640037 0.54
SCHEMBL104998 0.50
SCHEMBL4411441 0.47
SCHEMBL2396940 0.47
SCHEMBL14973298 0.47
SCHEMBL4410218 0.47
SCHEMBL342505 0.47

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7344740-B2 Methods and apparatus to prevent, treat, and cure the symptoms of nausea caused by chemotherapy treatments of human cancers INHALATION, INC. (US) 2008-03-18 US disclosed
US-7150888-B1 Methods and apparatus to prevent colds, influenzaes, tuberculosis and opportunistic infections of the human respiratory system INHALATION, INC. (US) 2006-12-19 US disclosed
US-7048953-B2 Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS) INHALATION, INC. (US) 2006-05-23 US disclosed
US-20050158411-A1 Methods and apparatus to prevent, treat, and cure the symptoms of nauea caused by chemotherapy treatments of human cancers INHALATION, INC. 2005-07-21 US disclosed
US-20040009245-A1 Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS) INHALATION, INC. 2004-01-15 US disclosed
US-6447816-B1 Methods and apparatus to prevent colds, flus, and infections of the human respiratory system INHALATION, INC. 2002-09-10 US disclosed